446(top 0.1%)
PR articles
9.3K(top 1%)
PR citations
49(top 1%)
PR h-index
57(top 1%)
h-index
557
documents
13.5K
doc citations
2.1K
citing journals
100
times ranked

Publications

483 peer-reviewed articles • 10,729 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1Acceptability and willingness to pay for a hypothetical HIV vaccine in Brazil and the implications: a cross-sectional study1.43Citations (PDF)
2Pilot Study to Evaluate Patients’ Understanding of Key Terms and Aspects of Antimicrobial Use in a Rural Province in South Africa Findings and Implications
Advances in Human Biology, 2025, 15, 108-112
0.320Citations (PDF)
3Identifying targets for antibiotic stewardship interventions in pediatric patients in Punjab, Pakistan: point prevalence surveys using AWaRe guidance1.76Citations (PDF)
4Knowledge, Attitudes, Motivations, Expectations, and Systemic Factors Regarding Antimicrobial Use Amongst Community Members Seeking Care at the Primary Healthcare Level: A Scoping Review
Antibiotics, 2025, 14, 78
4.115Citations (PDF)
5Knowledge, attitudes, motivations and expectations regarding antimicrobial use among community members seeking care at the primary healthcare level: a scoping review protocol
BMJ Open, 2025, 15, e088769
1.97Citations (PDF)
6Understanding patient and community members views regarding antimicrobial use: A scoping review2.10Citations (PDF)
7Impact of COVID-19 pandemic on the prescribing pattern of oral anticoagulants in the English primary care setting: a population-based segmented interrupted time series analysis of over 53 million individuals2.52Citations (PDF)
8Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries1.847Citations (PDF)
9The budget impact analysis of nicotine replacement therapy among patients who smoke tobacco and have mental illness in South Africa and the implications2.52Citations (PDF)
10Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries1.843Citations (PDF)
11Parental Awareness and Practices of Self-medication with Antibiotics among Hospitalised Children in Pakistan: Findings and Implications from a Cross-sectional Study
Advances in Human Biology, 2025, 15, 386-396
0.31Citations (PDF)
12A retrospective clinical evaluation of the quality of antibiotic use in treating ear, nose and throat infections in ambulatory care setting of a teaching hospital in Ghana: findings and implications2.63Citations (PDF)
13Knowledge, Attitudes, and Practices of Iraqi Parents Regarding Antibiotic Use in Children and the Implications
Antibiotics, 2025, 14, 376
4.114Citations (PDF)
14Surge of branded generics and antimicrobial resistance: analyzing the antibiotic market dynamics in Pakistan through the WHO essential medicines and AWaRe lens3.88Citations (PDF)
15Users’ Perceptions of Access to and Quality of Public Health Services in Brazil: A Cross-Sectional Study in Metropolitan Rio de Janeiro, Including Pharmaceutical Services2.91Citations (PDF)
16Barriers to Compliance with National Guidelines Among Children Hospitalized with Community-Acquired Pneumonia in Vietnam and the Implications
Antibiotics, 2025, 14, 709
4.16Citations (PDF)
17Antibiotic Use in Pediatric Care in Ghana: A Call to Action for Stewardship in This Population
Antibiotics, 2025, 14, 779
4.10Citations (PDF)
18Introduction of Biopharmaceuticals in Europe: A Cross-Sectional Study of Early Diffusion Patterns and Data Availability
BioDrugs, 2025, 39, 735-751
6.20Citations (PDF)
19Bacterial co-infections, secondary infections and antimicrobial use among hospitalized COVID-19 patients in the sixth wave in Pakistan: findings and implications3.88Citations (PDF)
20Potential Strategies to Limit Inappropriate Purchasing of Antibiotics without a Prescription in a Rural Province in South Africa: Pilot Study and the Implications
Advances in Human Biology, 2024, 14, 60-67
0.316Citations (PDF)
21Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study
PLoS ONE, 2024, 19, e0297626
2.315Citations (PDF)
22Short-term COVID-19 vaccine adverse effects among adults in Ekiti State, Nigeria2.10Citations (PDF)
23An Assessment of the Current Level of Implementation of the Core Elements of Antimicrobial Stewardship Programs in Public Hospitals in Ghana
Hospital Pharmacy, 2024, 59, 367-377
0.715Citations (PDF)
24Pilot Study to Evaluate the Feasibility of a Patient Questionnaire for the Purpose of Investigating the Extent of Purchasing Antibiotics without a Prescription in a Rural Province in South Africa: Rationale and Implications
Advances in Human Biology, 2024, 14, 138-147
0.313Citations (PDF)
25Managing infectious diarrhea among young children in community pharmacies in Saudi Arabia and the implications for AMR1.72Citations (PDF)
26Assessment of rational antibiotic use among children being treated in primary care facilities in Punjab, Pakistan: findings and implications0.56Citations (PDF)
27Users’ Perceptions of Access to and Quality of Unified Health System Services in Brazil: A Cross-Sectional Study and Implications to Healthcare Management Challenges2.96Citations (PDF)
28Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis3.82Citations (PDF)
29Mobile Colistin-Resistant Genes mcr-1, mcr-2, and mcr-3 Identified in Diarrheal Pathogens among Infants, Children, and Adults in Bangladesh: Implications for the Future
Antibiotics, 2024, 13, 534
4.19Citations (PDF)
30Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals3.89Citations (PDF)
31Resistance and Co-Resistance of Metallo-Beta-Lactamase Genes in Diarrheal and Urinary-Tract Pathogens in Bangladesh
Microorganisms, 2024, 12, 1589
3.87Citations (PDF)
32Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya1.80Citations (PDF)
33Predictors and outcomes of patients with COVID-19 admitted to intensive care units in Pakistan and the development of nosocomial fungal infections: Findings and implications
IJID Regions, 2024, 13, 100445
1.52Citations (PDF)
34Development of quality indicators for hypertension management at the primary health care level in South Africa2.54Citations (PDF)
35Community pharmacists’ knowledge, beliefs, and perceived barriers toward vaccination services at community pharmacies: A cross-sectional study from Saudi Arabia3.14Citations (PDF)
36Identifying AWaRe indicators for appropriate antibiotic use: a narrative review3.142Citations (PDF)
37Culture-Independent Quantitative PCR Detected Mobilized Colistin Resistance Genes (mcr-1, mcr-2, mcr-3, mcr-4, and mcr-5) in Chicken Gut Contents in Bangladesh
Sci, 2024, 6, 76
2.53Citations (PDF)
38Vaccine uptake, associated factors and reasons for vaccination status among the South African elderly; findings and next steps
PLoS ONE, 2024, 19, e0314098
2.35Citations (PDF)
39Paediatricians’ knowledge, perceptions, preparedness and involvement towards paediatric antimicrobial stewardship in Pakistan: findings and the implications1.810Citations (PDF)
40Drug-resistant tuberculosis treatment success predictors in Namibia1.81Citations (PDF)
41Challenges to the delivery of clinical diabetes services in Ghana created by the COVID-19 pandemic2.313Citations (PDF)
42Adherence to WHO Criteria on Drug Promotion Literature: An Exploratory Study From a Tertiary Healthcare Facility in South-West Nigeria
Hospital Pharmacy, 2023, 58, 62-69
0.76Citations (PDF)
43Economic Evaluation of Immune Tolerance Induction in Children With Severe Hemophilia A and High-Responding Inhibitors: A Cost-Effectiveness Analysis of Prophylaxis With Emicizumab1.39Citations (PDF)
44Understanding of Final Year Medical, Pharmacy and Nursing Students in Pakistan towards Antibiotic Use, Antimicrobial Resistance and Stewardship: Findings and Implications
Antibiotics, 2023, 12, 135
4.111Citations (PDF)
45Low influenza vaccine uptake by healthcare workers caring for the elderly in South African old age homes and primary healthcare facilities
BMC Public Health, 2023, 23,
3.113Citations (PDF)
46Effect of tenofovir containing ART on renal function in patients with moderate/severe reduced creatinine clearance at baseline: A retrospective study at two referral hospitals in Namibia2.23Citations (PDF)
47Point Prevalence Survey of Antimicrobial Use during the COVID-19 Pandemic among Different Hospitals in Pakistan: Findings and Implications
Antibiotics, 2023, 12, 70
4.121Citations (PDF)
48Breast Cancer Management in the Era of Covid-19; Key Issues, Contemporary Strategies, and Future Implications
Breast Cancer: Targets and Therapy, 2023, Volume 15, 51-89
2.612Citations (PDF)
49Antimicrobial Management of Skin and Soft Tissue Infections among Surgical Wards in South Africa: Findings and Implications
Antibiotics, 2023, 12, 275
4.19Citations (PDF)
50Trends in the utilization of medicines sold in the private sector post- registration in South Africa and the implications for similar countries
BMC Public Health, 2023, 23,
3.12Citations (PDF)
51Introduction of managed entry agreements in Korea: Problem, policy, and politics3.88Citations (PDF)
52Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones: Implications and future research2.00Citations (PDF)
53Knowledge, attitudes and practices of healthcare professionals on the use of an electronic stock visibility and management tool in a middle-income country: Implications for access to medicines0.78Citations (PDF)
54Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications
Antibiotics, 2023, 12, 283
4.15Citations (PDF)
55Knowledge, Attitude and Practices of Self-Medication Including Antibiotics among Health Care Professionals during the COVID-19 Pandemic in Pakistan: Findings and Implications
Antibiotics, 2023, 12, 481
4.112Citations (PDF)
56Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study1.33Citations (PDF)
57Antibiotic Overprescribing among Neonates and Children Hospitalized with COVID-19 in Pakistan and the Implications
Antibiotics, 2023, 12, 646
4.114Citations (PDF)
58Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates1.83Citations (PDF)
59Antibiotic Utilization Patterns for Different Wound Types among Surgical Patients: Findings and Implications
Antibiotics, 2023, 12, 678
4.111Citations (PDF)
60Current Antibiotic Use Among Hospitals in the sub-Saharan Africa Region; Findings and Implications
Infection and Drug Resistance, 2023, Volume 16, 2179-2190
3.449Citations (PDF)
61Impact of Lockdown Measures on Health Outcomes of Adults with Type 2 Diabetes Mellitus in Bangladesh
Healthcare (Switzerland), 2023, 11, 1191
2.11Citations (PDF)
62Knowledge of Community Pharmacists in Saudi Arabia Regarding Human Monkeypox, Its Management, Prevention, and Vaccination: Findings and Implications
Vaccines, 2023, 11, 878
2.914Citations (PDF)
63Short-term adverse effects of COVID-19 vaccines after the first, second, and booster doses: a cross-sectional survey from Punjab, Pakistan, and the implications0.86Citations (PDF)
64Antimicrobial Dispensing Practices during COVID-19 and the Implications for Pakistan
Antibiotics, 2023, 12, 1018
4.114Citations (PDF)
65COVID-19 Vaccination Status as Well as Factors Associated with COVID-19 Vaccine Acceptance and Hesitancy among Prisoners and the Implications
Vaccines, 2023, 11, 1081
2.95Citations (PDF)
66Airport-based pharmacies: Products, services and challenges essential for patients in a global travel landscape1.70Citations (PDF)
67Antibiotic Susceptibility Surveillance in the Punjab Province of Pakistan: Findings and Implications
Medicina (Lithuania), 2023, 59, 1215
2.029Citations (PDF)
68COVID-19 Vaccines Status, Acceptance and Hesitancy among Maintenance Hemodialysis Patients: A Cross-Sectional Study and the Implications for Pakistan and Beyond
Vaccines, 2023, 11, 904
2.97Citations (PDF)
69Patient safety culture at the unit level of a tertiary hospital in South Africa: a survey study0.54Citations (PDF)
70Ongoing Strategies to Improve Antimicrobial Utilization in Hospitals across the Middle East and North Africa (MENA): Findings and Implications
Antibiotics, 2023, 12, 827
4.139Citations (PDF)
7111-Year Trend in Antibiotic Consumption in a South-Eastern European Country; the Situation in Albania and the Implications for the Future
Antibiotics, 2023, 12, 882
4.112Citations (PDF)
72Perceptions of and Practical Experience with the National Surveillance Centre in Managing Medicines Availability Amongst Users within Public Healthcare Facilities in South Africa: Findings and Implications
Healthcare (Switzerland), 2023, 11, 1838
2.116Citations (PDF)
73Using Culture Sensitivity Reports to Optimize Antimicrobial Therapy: Findings and Implications of Antimicrobial Stewardship Activity in a Hospital in Pakistan
Medicina (Lithuania), 2023, 59, 1237
2.020Citations (PDF)
74Antimicrobial Stewardship for Outpatients with Chronic Bone and Joint Infections in the Orthopaedic Clinic of an Academic Tertiary Hospital, South Africa
Antibiotics, 2023, 12, 1142
4.16Citations (PDF)
75Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications
Hospital Practice (1995), 2023, 51, 223-232
1.04Citations (PDF)
76Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
Antibiotics, 2023, 12, 1299
4.110Citations (PDF)
77COVID-19 Vaccine Acceptance and Hesitancy among Healthcare Workers in Lusaka, Zambia; Findings and Implications for the Future
Vaccines, 2023, 11, 1350
2.915Citations (PDF)
78Knowledge, practices and risk awareness regarding non-prescription weight loss supplements among university students in UAE1.11Citations (PDF)
79A Multicenter Cross-Sectional Survey of Knowledge, Attitude, and Practices of Healthcare Professionals towards Antimicrobial Stewardship in Ghana: Findings and Implications
Antibiotics, 2023, 12, 1497
4.118Citations (PDF)
80Awareness and Practices towards Vaccinating Their Children against COVID-19: A Cross-Sectional Study among Pakistani Parents
Healthcare (Switzerland), 2023, 11, 2378
2.14Citations (PDF)
81A Narrative Review of Antibiotic Prescribing Practices in Primary Care Settings in South Africa and Potential Ways Forward to Reduce Antimicrobial Resistance
Antibiotics, 2023, 12, 1540
4.139Citations (PDF)
82Healthcare-associated infections among neonates and children in Pakistan: findings and the implications from a point prevalence survey
Journal of Hospital Infection, 2023, 141, 142-151
2.32Citations (PDF)
83Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa2.52Citations (PDF)
84Knowledge of Human Monkeypox Infection among Final Year Medical, Pharmacy, and Nursing Students: A Multicenter, Cross-Sectional Analysis from Pakistan
Healthcare (Switzerland), 2023, 11, 2777
2.114Citations (PDF)
85Point Prevalence Survey of Antimicrobial Use and Resistance during the COVID-19 Era among Hospitals in Saudi Arabia and the Implications
Antibiotics, 2023, 12, 1609
4.14Citations (PDF)
86Emicizumab prophylaxis for people with hemophilia A: Waste estimation and the Brazilian perspective2.91Citations (PDF)
87Tackling antimicrobial resistance in primary care facilities across Pakistan: Current challenges and implications for the future3.731Citations (PDF)
88Off-Label and Unlicenced Medicine Use among Hospitalised Children in South Africa: Practice and Policy Implications1.33Citations (PDF)
89Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana3.827Citations (PDF)
90The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya
Cureus, 2023, ,
0.60Citations (PDF)
91Knowledge and Perceptions of Final-Year Nursing Students Regarding Antimicrobials, Antimicrobial Resistance, and Antimicrobial Stewardship in South Africa: Findings and Implications to Reduce Resistance
Antibiotics, 2023, 12, 1742
4.11Citations (PDF)
92A Narrative Review of Recent Antibiotic Prescribing Practices in Ambulatory Care in Tanzania: Findings and Implications
Medicina (Lithuania), 2023, 59, 2195
2.019Citations (PDF)
93Knowledge and Perceptions of Final-Year Nursing Students Regarding Antimicrobials, Antimicrobial Resistance, and Antimicrobial Stewardship in South Africa: Findings and Implications to Reduce Resistance
Antibiotics, 2023, 12, 1742
4.14Citations (PDF)
94Consumer willingness to pay for a hypothetical chikungunya vaccine in Brazil and the implications1.415Citations (PDF)
95Budget impact analysis of medicines: estimated values versus real-world evidence and the implications1.410Citations (PDF)
96Acceptability and willingness to pay for a hypothetical vaccine against SARS CoV-2 by the Brazilian consumer: a cross-sectional study and the implications1.415Citations (PDF)
97A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications3.827Citations (PDF)
98Progress on the national action plan of Pakistan on antimicrobial resistance (AMR): a narrative review and the implications3.883Citations (PDF)
99Antibiotic consumption among hospitalized neonates and children in Punjab province, Pakistan3.840Citations (PDF)
100Assessing smoking cessation services and pharmacotherapy in Namibia: findings and implications for future policy initiatives1.42Citations (PDF)
101Co-infections and antimicrobial use among hospitalized COVID-19 patients in Punjab, Pakistan: findings from a multicenter, point prevalence survey
Pathogens and Global Health, 2022, 116, 421-427
2.732Citations (PDF)
102Using mystery shoppers to determine practices pertaining to antibiotic dispensing without a prescription among community pharmacies in South Africa—a pilot survey1.842Citations (PDF)
103Willingness to pay for a hypothetical malaria vaccine in Brazil: a cross-sectional study and the implications2.37Citations (PDF)
104Key characteristics including sex, sexual orientation and internet use associated with worse mental health among university students in Brazil and implications
Journal of Public Health, 2022, 44, e487-e498
2.07Citations (PDF)
105Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study
Antibiotics, 2022, 11, 105
4.131Citations (PDF)
106Acceptability and Consumer Willingness to pay for a hypothetical HIV vaccine in Northern Brazil: A cross-sectional study and the implications0.23Citations (PDF)
107Survival Analysis of COPD Patients in a 13-Year Nationwide Cohort Study of the Brazilian National Health System1.71Citations (PDF)
108Demand of COVID-19 medicines without prescription among community pharmacies in Jodhpur, India: Findings and implications1.012Citations (PDF)
109Barriers and facilitators of adherence to antiretroviral treatment at a public health facility in Ghana: a mixed method study
Hospital Practice (1995), 2022, 50, 110-117
1.09Citations (PDF)
110Social Media and COVID-19—Perceptions and Public Deceptions of Ivermectin, Colchicine and Hydroxychloroquine: Lessons for Future Pandemics
Antibiotics, 2022, 11, 445
4.146Citations (PDF)
111Multisystem Inflammatory Syndrome of a Neonate From a COVID-19-Infected Mother: A Case Report
Cureus, 2022, ,
0.65Citations (PDF)
112Sick leave duration as a potential marker of functionality and disease severity in depression2.811Citations (PDF)
113A national, multicentre, web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa2.330Citations (PDF)
114Antimicrobial Prescribing Confidence and Knowledge Regarding Drug Resistance: Perception of Medical Students in Malaysia and the Implications
Antibiotics, 2022, 11, 540
4.111Citations (PDF)
115Perceptions of managerial staff on the patient safety culture at a tertiary hospital in South Africa1.925Citations (PDF)
116A web-based point prevalence survey of antimicrobial use and quality indicators at Raleigh Fitkin Memorial Hospital in the Kingdom of Eswatini and the implications
Hospital Practice (1995), 2022, 50, 214-221
1.013Citations (PDF)
117Co-Infections, Secondary Infections, and Antimicrobial Use in Patients Hospitalized with COVID-19 during the First Five Waves of the Pandemic in Pakistan; Findings and Implications
Antibiotics, 2022, 11, 789
4.132Citations (PDF)
118Trends in Antihypertensive Medicine Utilization in the Republic of Srpska, Bosnia and Herzegovina: An Eleven-Year Follow-Up3.85Citations (PDF)
119Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries3.817Citations (PDF)
120The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis2.511Citations (PDF)
121Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements3.810Citations (PDF)
122Exploring Knowledge of Antibiotic Use, Resistance, and Stewardship Programs among Pharmacy Technicians Serving in Ambulatory Care Settings in Pakistan and the Implications
Antibiotics, 2022, 11, 921
4.115Citations (PDF)
123Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: a clinical audit study1.812Citations (PDF)
124Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications
Vaccines, 2022, 10, 1185
2.939Citations (PDF)
125Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
Expert Opinion on Drug Safety, 2022, 21, 1089-1111
2.6136Citations (PDF)
126A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications
Hospital Practice (1995), 2022, 50, 306-317
1.022Citations (PDF)
127Antimicrobial Utilization among Neonates and Children: A Multicenter Point Prevalence Study from Leading Children’s Hospitals in Punjab, Pakistan
Antibiotics, 2022, 11, 1056
4.130Citations (PDF)
128A National Survey of Dispensing Practice and Customer Knowledge on Antibiotic Use in Vietnam and the Implications
Antibiotics, 2022, 11, 1091
4.136Citations (PDF)
129Analysis of policies for use of medically important antibiotics in animals in Namibia: implications for antimicrobial stewardship3.85Citations (PDF)
130Knowledge, Attitudes, and Practices of Community Pharmacy Professionals on Poultry Antibiotic Dispensing, Use, and Bacterial Antimicrobial Resistance in Zambia: Implications on Antibiotic Stewardship and WHO AWaRe Classification of Antibiotics
Antibiotics, 2022, 11, 1210
4.141Citations (PDF)
131Coronavirus Disease 2019 (COVID-19) Pandemic across Africa: Current Status of Vaccinations and Implications for the Future
Vaccines, 2022, 10, 1553
2.939Citations (PDF)
132Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications1.821Citations (PDF)
133Determinants of the Empiric Use of Antibiotics by General Practitioners in South Africa: Observational, Analytic, Cross-Sectional Study
Antibiotics, 2022, 11, 1423
4.130Citations (PDF)
134Antibiotic Use and Stewardship Indicators in the First- and Second-Level Hospitals in Zambia: Findings and Implications for the Future
Antibiotics, 2022, 11, 1626
4.137Citations (PDF)
135Key Considerations From a Health Authority Perspective When Proton Pump Inhibitors Are Used to Treat Gastroesophageal Reflux Disease (GERD) and Their Implications
Cureus, 2022, ,
0.61Citations (PDF)
136Evaluation of Healthcare Students’ Knowledge on Antibiotic Use, Antimicrobial Resistance and Antimicrobial Stewardship Programs and Associated Factors in a Tertiary University in Ghana: Findings and Implications
Antibiotics, 2022, 11, 1679
4.130Citations (PDF)
137Knowledge, Attitudes, and Acceptance of COVID-19 Vaccines among Secondary School Pupils in Zambia: Implications for Future Educational and Sensitisation Programmes
Vaccines, 2022, 10, 2141
2.911Citations (PDF)
138Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
Antibiotics, 2022, 11, 1824
4.187Citations (PDF)
139Predictors and Outcomes of Healthcare-Associated Infections among Patients with COVID-19 Admitted to Intensive Care Units in Punjab, Pakistan; Findings and Implications
Antibiotics, 2022, 11, 1806
4.113Citations (PDF)
140Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks0.56Citations (PDF)
141Health equity and the usage of atypical antipsychotics within the Brazilian national health system: findings and implications1.41Citations (PDF)
142Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?
Journal of Chemotherapy, 2021, 33, 21-31
1.529Citations (PDF)
143Addressing antimicrobial resistance in Nigerian hospitals: exploring physicians prescribing behavior, knowledge, and perception of antimicrobial resistance and stewardship programs3.852Citations (PDF)
144A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan regional government of Northern Iraq: the need for urgent action3.831Citations (PDF)
145Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications2.555Citations (PDF)
146Alanine transaminase and hemoglobin appear to predict the occurrence of antituberculosis medication hepatotoxicity; findings and implications in Botswana3.83Citations (PDF)
147Availability and accessibility of monoclonal antibodies in Bosnia and Herzegovina: Findings and implications1.38Citations (PDF)
148The Budget Impact of Monoclonal Antibodies Used to Treat Metastatic Colorectal Cancer in Minas Gerais, Brazil2.53Citations (PDF)
149Compliance to hypertensive prescribing guidelines and blood pressure control in elderly patients in Namibia: findings and implications0.55Citations (PDF)
150Economic and social cost of epilepsy in Poland: 5-year analysis1.919Citations (PDF)
151Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications3.972Citations (PDF)
152Strategies to improve the availability of medicines in primary health care in Brazil: findings and implications2.35Citations (PDF)
153Availability of Medicines in Community Pharmacy to Manage Patients with COVID-19 in Kenya; Pilot Study and Implications0.337Citations (PDF)
154Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa
Hospital Practice (1995), 2021, 49, 184-193
1.019Citations (PDF)
155Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future1.840Citations (PDF)
156A cross-sectional study of the quality of life of patients living with type 1 diabetes treated with insulin glargine and neutral protamine Hagedorn insulin and the implications0.54Citations (PDF)
157Prevalence and factors associated with anxiety among university students of health sciences in Brazil: findings and implications0.313Citations (PDF)
158Influence of pharmaceutical services organization on the availability of essential medicines in a public health system2.35Citations (PDF)
159Ongoing efforts to improve the management of patients with diabetes in Bangladesh and the implications
Hospital Practice (1995), 2021, 49, 266-272
1.019Citations (PDF)
160A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications3.850Citations (PDF)
161Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
Life, 2021, 11, 528
2.6190Citations (PDF)
162The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future2.729Citations (PDF)
163Consumer willingness to pay for a hypothetical Chagas disease vaccine in Brazil: a cross-sectional study and the implications2.36Citations (PDF)
164Crizotinib Versus Conventional Chemotherapy in First-Line Treatment for ALK-Positive Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
Oncology and Therapy, 2021, 9, 505-524
2.610Citations (PDF)
165Current utilization patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future2.119Citations (PDF)
166Access to medicines in the Brazilian Unified Health System’s primary health care: assessment of a public policy2.33Citations (PDF)
167Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction
Antibiotics, 2021, 10, 996
4.129Citations (PDF)
168Pharmacists’ clinical knowledge and practice in the safe use of contraceptives: real knowledge vs. self-perception and the implications2.63Citations (PDF)
169Evidence-based public policy making for medicines across countries: findings and implications for the future2.352Citations (PDF)
170Antibiotics’ susceptibility patterns of bacterial isolates causing lower respiratory tract infections in ICU patients at referral hospitals in Namibia
Hospital Practice (1995), 2021, 49, 356-363
1.04Citations (PDF)
171Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis2.19Citations (PDF)
172Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications3.828Citations (PDF)
173Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications3.854Citations (PDF)
174The Expiry of Humira® Market Exclusivity and the Entry of Adalimumab Biosimilars in Europe: An Overview of Pricing and National Policy Measures3.863Citations (PDF)
175Healthcare Professionals’ Knowledge of Pharmacogenetics and Attitudes Towards Antimicrobial Utilization in Zambia: Implications for a Precision Medicine Approach to Reducing Antimicrobial Resistance3.819Citations (PDF)
176Real-world effectiveness of olanzapine and risperidone in the treatment of schizophrenia in Brazil over a 16-year follow-up period; findings and implications2.58Citations (PDF)
177Variations in the Consumption of Antimicrobial Medicines in the European Region, 2014–2018: Findings and Implications from ESAC-Net and WHO Europe3.836Citations (PDF)
178Assessing Utilisation and Expenditure on Long-Acting Insulin Analogues in Kenya; Findings and Implications for the Future0.38Citations (PDF)
179A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues
Vaccines, 2021, 9, 1387
2.971Citations (PDF)
180A Review of the Evidence on Attitudes, Perceived Impacts and Motivational Factors for European Member State Collaboration for Pricing and Reimbursement of Medicines: Time for the EEA Member States to Apply Their Experience and Expertise in Evidence-Based Decision Making to Their Current Pharmaceutical Policy Challenges3.82Citations (PDF)
181Antibiotic consumption at community pharmacies: A multicenter repeated prevalence surveillance using WHO methodology1.317Citations (PDF)
182Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future2.143Citations (PDF)
183Activities in Namibia to Limit the Prevalence and Mortality from COVID-19 Including Community Pharmacy Activities and the Implications0.336Citations (PDF)
184Prevalence and Factors Associated With Caesarean Delivery in Nepal: Evidence From a Nationally Representative Sample
Cureus, 2021, ,
0.62Citations (PDF)
185Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications0.910Citations (PDF)
186The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia3.882Citations (PDF)
187Effect of TDF-containing regimens on creatinine clearance in HIV patients in Namibia with a baseline CrCl <60ml/min; findings and implications
Hospital Practice (1995), 2020, 48, 35-40
1.02Citations (PDF)
188Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future2.1157Citations (PDF)
189Formulary Management Activities and Practice Implications Among Public Sector Hospital Pharmaceutical and Therapeutics Committees in a South African Province3.815Citations (PDF)
190A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?2.223Citations (PDF)
191Knowledge and Attitude of Physicians Towards the Cost of Commonly Prescribed Medicines: A Case Study in Three Nigerian Healthcare Facilities1.310Citations (PDF)
192Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis1.846Citations (PDF)
193Uptake of Biosimilar Infliximab in the UK, France, Japan, and Korea: Budget Savings or Market Expansion Across Countries?3.855Citations (PDF)
194Utility of medicines information leaflets in hypertensive care in a setting with low health literacy: A cross-sectional study1.33Citations (PDF)
195Integrative Review of Managed Entry Agreements: Chances and Limitations
Pharmacoeconomics, 2020, 38, 1165-1185
3.649Citations (PDF)
196Practical Implications From European Hospital Pharmacists on Prospective Risk Assessment for Medicine Shortages2.412Citations (PDF)
197Sale of WHO AWaRe groups antibiotics without a prescription in Pakistan: a simulated client study1.998Citations (PDF)
198Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future3.8185Citations (PDF)
199Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries1.83Citations (PDF)
200Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study2.528Citations (PDF)
201Challenges facing drug utilization research in the Latin American region1.926Citations (PDF)
202Point prevalence surveys of antimicrobial use: a systematic review and the implications3.874Citations (PDF)
203Compliance to prescribing guidelines among public health care facilities in Namibia; findings and implications2.259Citations (PDF)
204Risks in Antibiotic Substitution Following Medicine Shortage: A Health-Care Failure Mode and Effect Analysis of Six European Hospitals2.432Citations (PDF)
205Statin prescription among patients with type 2 diabetes in Botswana: findings and implications2.921Citations (PDF)
206Nature and sources of poisoning in patients admitted to a referral hospital in Gaborone, Botswana; findings and implications
Hospital Practice (1995), 2020, 48, 100-107
1.06Citations (PDF)
207Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
Hospital Practice (1995), 2020, 48, 51-67
1.044Citations (PDF)
208Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications2.5110Citations (PDF)
209Mapping of Current Obstacles for Rationalizing Use of Medicines (CORUM) in Europe: Current Situation and Potential Solutions3.822Citations (PDF)
210Effectiveness of Maintenance Immunosuppression Therapies in a Matched-Pair Analysis Cohort of 16 Years of Renal Transplant in the Brazilian National Health System2.99Citations (PDF)
211Assessment of antimicrobial use and prescribing practices among pediatric inpatients in Zimbabwe
Journal of Chemotherapy, 2020, 32, 456-459
1.516Citations (PDF)
212Drug utilization review of tramadol hydrochloride in a regional hospital in South Africa; findings and implications
Hospital Practice (1995), 2020, 48, 92-99
1.04Citations (PDF)
213Availability and Use of Therapeutic Interchange Policies in Managing Antimicrobial Shortages among South African Public Sector Hospitals; Findings and Implications
Antibiotics, 2020, 9, 4
4.131Citations (PDF)
214Profiles of patients on warfarin anticoagulation therapy in a leading tertiary referral hospital in Kenya; findings and implications for Kenya1.83Citations (PDF)
215Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship1.880Citations (PDF)
216Prevalence and treatment of neurological and psychiatric disorders among tertiary hospitals in Pakistan; findings and implications
Hospital Practice (1995), 2020, 48, 145-160
1.09Citations (PDF)
217Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications3.830Citations (PDF)
218Antibiotic resistance and sensitivity pattern of Metallo-β-Lactamase Producing Gram-Negative Bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh
Hospital Practice (1995), 2020, 48, 128-136
1.017Citations (PDF)
219Funding and Service Organization to Achieve Universal Health Coverage for Medicines: An Economic Evaluation of the Best Investment and Service Organization for the Brazilian Scenario.3.86Citations (PDF)
220Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district2.038Citations (PDF)
221Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future3.8117Citations (PDF)
222Comparative persistence of anti-tumor necrosis factor therapy in ankylosing spondylitis patients: a multicenter international study2.117Citations (PDF)
223Predictors of loss to follow-up of tuberculosis cases under the DOTS programme in Namibia
ERJ Open Research, 2020, 6, 00030-2019
2.516Citations (PDF)
224Systematic Review on the Therapeutic Options for COVID-19: Clinical Evidence of Drug Efficacy and Implications
Infection and Drug Resistance, 2020, Volume 13, 4673-4695
3.453Citations (PDF)
225Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future2.791Citations (PDF)
226Can local policies on biosimilars optimize the use of freed resources – experiences from Italy
GaBI Journal, 2020, 9, 183-187
0.18Citations (PDF)
227Examining the uptake of predictive BRCA testing in the UK; findings and implications3.08Citations (PDF)
228Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital
Hospital Practice (1995), 2019, 47, 53-58
1.055Citations (PDF)
229Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future2.16Citations (PDF)
230Snapshot of antimicrobial stewardship programs in the hospitals of Pakistan: findings and implications
Heliyon, 2019, 5, e02159
3.235Citations (PDF)
231Medicine Shortages: Gaps Between Countries and Global Perspectives3.8113Citations (PDF)
232The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications
Clinics, 2019, 74, e950
1.816Citations (PDF)
233Healthcare-associated infections including neonatal bloodstream infections in a leading tertiary hospital in Botswana
Hospital Practice (1995), 2019, 47, 203-210
1.039Citations (PDF)
234Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence2.318Citations (PDF)
235Predictors of Multidrug-Resistant Tuberculosis (MDR-TB) in Sudan
Antibiotics, 2019, 8, 90
4.127Citations (PDF)
236Essential and forgotten antibiotics: An inventory in low- and middle-income countries3.919Citations (PDF)
237Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications3.892Citations (PDF)
238Antimicrobial prescribing and determinants of antimicrobial resistance: a qualitative study among physicians in Pakistan2.236Citations (PDF)
239Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice
Journal of Chemotherapy, 2019, 31, 378-387
1.584Citations (PDF)
240Stage at diagnosis and stage-specific survival of breast cancer in Latin America and the Caribbean: A systematic review and meta-analysis
PLoS ONE, 2019, 14, e0224012
2.350Citations (PDF)
241Isoniazid acetylation phenotypes in the Sudanese population; findings and implications1.57Citations (PDF)
242Assessment of multidrug-resistant tuberculosis (MDR-TB) treatment outcomes in Sudan; findings and implications3.829Citations (PDF)
243Prescribing patterns of physicians working in both the direct and indirect treatment sectors in Iran; findings and implications0.518Citations (PDF)
244Effectiveness of community-based DOTS strategy on tuberculosis treatment success rates in Namibia1.317Citations (PDF)
245Point prevalence surveys of health-care-associated infections: a systematic review
Pathogens and Global Health, 2019, 113, 191-205
2.7134Citations (PDF)
246Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin’s Lymphoma in Kenya: A descriptive, situation analysis study2.513Citations (PDF)
247A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications
Hospital Practice (1995), 2019, 47, 149-154
1.08Citations (PDF)
248Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications2.413Citations (PDF)
249Trends in BRCA testing and socioeconomic deprivation3.07Citations (PDF)
250Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications2.3104Citations (PDF)
251Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications
Hospital Practice (1995), 2019, 47, 88-95
1.038Citations (PDF)
252Off-label use of pentazocine and the associated adverse events among pediatric surgical patients in a tertiary hospital in Northern Nigeria: a retrospective chart review2.18Citations (PDF)
253A Cost Analysis of Haemodialysis and Peritoneal Dialysis for the Management of End-Stage Renal Failure At an Academic Hospital in Pretoria, South Africa
PharmacoEconomics - Open, 2019, 3, 631-641
1.634Citations (PDF)
254Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health2.54Citations (PDF)
255A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications3.8106Citations (PDF)
256Discontinuation, persistence and adherence to subcutaneous biologics delivered via a homecare route to Scottish adults with rheumatic diseases: a retrospective study
BMJ Open, 2019, 9, e027059
1.914Citations (PDF)
257Glycaemic, blood pressure and low-density lipoprotein-cholesterol control among patients with diabetes mellitus in a specialised clinic in Botswana: a cross-sectional study
BMJ Open, 2019, 9, e026807
1.913Citations (PDF)
258Adjustments of medication dosages in patients with renal impairment in Botswana; findings and implications to improve patient care
Hospital Practice (1995), 2019, 47, 231-240
1.05Citations (PDF)
259Pattern of inappropriate antibiotic use among hospitalized patients in Pakistan: a longitudinal surveillance and implications3.975Citations (PDF)
260Pharmacotherapeutic interventions for bipolar disorder type II: addressing multiple symptoms and approaches with a particular emphasis on strategies in lower and middle-income countries2.142Citations (PDF)
261Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications1.074Citations (PDF)
262Initiatives to reduce postoperative surgical site infections of the head and neck cancer surgery with a special emphasis on developing countries2.524Citations (PDF)
263A multicenter point prevalence survey of healthcare–associated infections in Pakistan: Findings and implications1.844Citations (PDF)
264Knowledge regarding medicines management of type 2 diabetes amongst patients attending a Community Health Centre in South Africa0.515Citations (PDF)
265Impact of EU risk assessment process and administrative regulations for manufacturers of combined hormonal contraceptive prescribing. An analysis of developments in Germany and the implications2.14Citations (PDF)
266Determinants of glycemic control among diabetes mellitus patients in a tertiary clinic in Gaborone, Botswana: findings and implications
Hospital Practice (1995), 2019, 47, 34-41
1.07Citations (PDF)
267Antimicrobial Medicines Consumption in Eastern Europeand Central Asia – An Updated Cross-National Study and Assessment of QuantitativeMetrics for Policy Action3.862Citations (PDF)
268Implementation and monitoring of decisions by pharmacy and therapeutics committees in South African public sector hospitals2.523Citations (PDF)
269Consumer willingness to pay for a hypothetical Zika vaccine in Brazil and the implications1.422Citations (PDF)
270Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India
PharmacoEconomics - Open, 2019, 4, 331-342
1.619Citations (PDF)
271Indicator of access to medicines in relation to the multiple dimensions of access2.314Citations (PDF)
272Pricing of oral generic cancer medicines in 25 European countries; findings and implications
GaBI Journal, 2019, 8, 49-70
0.135Citations (PDF)
273Ever-changing landscape of biosimilars in Canada; findings and implications from a global perspective
GaBI Journal, 2019, 8, 93-97
0.112Citations (PDF)
274Cost-effectiveness thresholds: methods for setting and examples from around the world1.454Citations (PDF)
275Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries?2.311Citations (PDF)
276Creating and evaluating an opportunity for medication reconciliation in the adult population of South Africa to improve patient care
Hospital Practice (1995), 2018, 46, 110-120
1.07Citations (PDF)
277Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications
Hospital Practice (1995), 2018, 46, 128-136
1.083Citations (PDF)
278Are pharmacists’ good knowledge and awareness on antibiotics taken for granted? The situation in Albania and future implications across countries2.361Citations (PDF)
279Utilization and Expenditure of Anti-cancer Medicines in Kosovo: Findings and Implications
PharmacoEconomics - Open, 2018, 2, 423-432
1.612Citations (PDF)
280Quality of Life of Patients with Type 1 Diabetes Mellitus Using Insulin Analog Glargine Compared with NPH Insulin: A Systematic Review and Policy Implications
Patient, 2018, 11, 377-389
2.240Citations (PDF)
281Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications
Hospital Practice (1995), 2018, 46, 77-87
1.042Citations (PDF)
282Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications3.825Citations (PDF)
283Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications
Hospital Practice (1995), 2018, 46, 97-102
1.047Citations (PDF)
284Statin use in Brazil: findings and implications2.123Citations (PDF)
285Health-related quality of life and associated factors among patients with diabetes mellitus in Botswana0.357Citations (PDF)
286Liver enzyme elevations in a cohort of HIV/AIDS patients on first-line antiretroviral therapy in Namibia: Findings and implications0.317Citations (PDF)
287Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study2.077Citations (PDF)
288Policy Change and the National Essential Medicines List Development Process in Brazil between 2000 and 2014: Has the Essential Medicine Concept been Abandoned?2.817Citations (PDF)
289Antibiotic prescribing practices in the presence of extended-spectrum β-lactamase (ESBL) positive organisms in an adult intensive care unit in South Africa – A pilot study0.37Citations (PDF)
290Drug and therapeutics committees in Nigeria: evaluation of scope and functionality2.528Citations (PDF)
291Crohn’s Disease Treatment Expenditures over Fifteen Years of Follow-Up0.00Citations (PDF)
292Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care3.814Citations (PDF)
293Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital3.810Citations (PDF)
294Antibiotic consumption and antimicrobial resistance in Poland; findings and implications3.970Citations (PDF)
295Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine
Expert Review of Vaccines, 2018, 17, 1123-1133
4.022Citations (PDF)
296Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
BioDrugs, 2018, 32, 585-606
6.241Citations (PDF)
297Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets2.7136Citations (PDF)
298Availability and Affordability of Drugs With a Conditional Approval by the European Medicines Agency; Comparison of Korea With Other Countries and the Implications3.819Citations (PDF)
299Predictors of tuberculosis treatment success under the DOTS program in Namibia2.412Citations (PDF)
300Effectiveness and safety of insulin glargine versus detemir analysis in patients with type 1 diabetes: systematic review and meta-analysis3.513Citations (PDF)
301The long-term costs for treating multiple sclerosis in a 16-year retrospective cohort study in Brazil
PLoS ONE, 2018, 13, e0199446
2.326Citations (PDF)
302Prevalence of chronic kidney disease using estimated glomerular filtration rate among diabetes patients attending a tertiary clinic in Botswana
Hospital Practice (1995), 2018, 46, 214-220
1.010Citations (PDF)
303Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries3.889Citations (PDF)
304Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications3.843Citations (PDF)
305Costs in the Treatment of Schizophrenia in Adults Receiving Atypical Antipsychotics: An 11-Year Cohort in Brazil2.529Citations (PDF)
306Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications1.436Citations (PDF)
307Impact of a pharmacist-driven pharmacovigilance system in a secondary hospital in the Gauteng Province of South Africa
Hospital Practice (1995), 2018, 46, 221-228
1.028Citations (PDF)
308Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates2.521Citations (PDF)
309Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future
Journal of Medical Economics, 2018, 21, 878-887
2.253Citations (PDF)
310Did we see it Coming? An Evaluation of the Swedish Early Awareness and Alert System2.511Citations (PDF)
311Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa2.330Citations (PDF)
312Ongoing activities to influence the prescribing of proton pump inhibitors within the Scottish National Health Service: their effect and implications
GaBI Journal, 2018, 7, 142-151
0.114Citations (PDF)
313Relationship between adherence and health-related quality of life among HIV-patients in South Africa: findings and implications0.325Citations (PDF)
314An analysis of policies for cotrimoxazole, amoxicillin and azithromycin use in Namibia's public sector: Findings and therapeutic implications3.023Citations (PDF)
315CYD-TDV dengue vaccine: systematic review and meta-analysis of efficacy, immunogenicity and safety2.343Citations (PDF)
316Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications1.414Citations (PDF)
317Frequency and evaluation of the perceptions towards caesarean section among pregnant women attending public hospitals in Pakistan and the implications
Hospital Practice (1995), 2017, 45, 104-110
1.012Citations (PDF)
318Assessment of medication adherence among type 2 diabetic patients in Quetta city, Pakistan
Postgraduate Medicine, 2017, 129, 637-643
2.522Citations (PDF)
319Federal procurement of unlicensed medicines in Brazil; findings and implications1.413Citations (PDF)
320Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications3.865Citations (PDF)
321The transparency of published health technology assessment-based recommendations on pharmaceutical reimbursement in Poland1.48Citations (PDF)
322Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications2.39Citations (PDF)
323The clinical effectiveness of insulin glargine in patients with Type I diabetes in Brazil: findings and implications2.312Citations (PDF)
324The Implementation of Managed Entry Agreements in Central and Eastern Europe: Findings and Implications
Pharmacoeconomics, 2017, 35, 1271-1285
3.6108Citations (PDF)
325Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications2.547Citations (PDF)
326Knowledge, attitudes and perspective on adverse drug reaction reporting in a public sector hospital in South Africa: baseline analysis
Hospital Practice (1995), 2017, 45, 238-245
1.032Citations (PDF)
327Compliance with the primary health care treatment guidelines and the essential medicines list in the management of sexually transmitted infections in correctional centres in South Africa: findings and implications3.848Citations (PDF)
328Structure and activities of pharmacy and therapeutics committees among public hospitals in South Africa; findings and implications2.535Citations (PDF)
329Knowledge of hypertension and its management among hypertensive patients on chronic medicines at primary health care public sector facilities in South Africa; findings and implications1.828Citations (PDF)
330Patterns of drugs prescribed for dental outpatients in Nigeria: findings and implications1.518Citations (PDF)
331Evidence on the cost-effectiveness of lifelong antiretroviral therapy for prevention of mother-to-child transmission of HIV: implications for resource-limited countries in sub-Saharan Africa1.46Citations (PDF)
332Forecasting Pharmaceutical Expenditure In Europe: Adjusting For The Impact Of Rebates And Discounts
Value in Health, 2017, 20, A664
1.90Citations (PDF)
333Assessment of prescribing practices at the primary healthcare facilities in Botswana with an emphasis on antibiotics: Findings and implications3.053Citations (PDF)
334Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications2.183Citations (PDF)
335Off-label prescribing for children with chronic diseases in Nigeria; findings and implications2.68Citations (PDF)
336A pilot study evaluating the prescribing of ceftriaxone in hospitals in Ghana: findings and implications
Hospital Practice (1995), 2017, 45, 143-149
1.024Citations (PDF)
337Evaluating the Treatment Costs for Uncomplicated Malaria at a Public Healthcare Facility in Nigeria and the Implications
PharmacoEconomics - Open, 2017, 1, 185-194
1.635Citations (PDF)
338Medicines dispensers' knowledge on the implementation of an artemisinin-based combination therapy policy for the treatment of uncomplicated malaria in Tanzania0.511Citations (PDF)
339Consumer Willingness to Pay for Dengue Vaccine (CYD-TDV, Dengvaxia®) in Brazil; Implications for Future Pricing Considerations3.837Citations (PDF)
340Adaptive Pathways: Possible Next Steps for Payers in Preparation for Their Potential Implementation3.837Citations (PDF)
341The Early Awareness and Alert System in Sweden: History and Current Status3.840Citations (PDF)
342Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study3.8155Citations (PDF)
343The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil
Pharmacoeconomics, 2017, 36, 161-173
3.618Citations (PDF)
344Policies for biosimilar uptake in Europe: An overview
PLoS ONE, 2017, 12, e0190147
2.3229Citations (PDF)
345Determinants of the Effectiveness of Antimicrobial Prophylaxis among Neurotrauma Patients at a Referral Hospital in Kenya: Findings and Implications0.23Citations (PDF)
346The Potential Effect of Using the Cockcroft-Gault Method on Tenofovir-Associated Renal Impairment Reports and on Clinical Decisions Regarding Tenofovir Use in Individual Patients: Implications for the Future0.23Citations (PDF)
347Patent expiry and costs for anticancer medicines for clinical use
GaBI Journal, 2017, 6, 105-106
0.119Citations (PDF)
348Strategies for pricing of pharmaceuticals and generics in developing countries
GaBI Journal, 2017, 6, 58-60
0.11Citations (PDF)
349Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future3.827Citations (PDF)
350Implementation of clinical guidelines in Brazil: should academic detailing be used?0.515Citations (PDF)
351Effect of changing from first- to second-line antiretroviral therapy on renal function: a retrospective study based on data from a single health facility in Namibia3.814Citations (PDF)
352The Transparency Of Published Recommendations On Reimbursement Of Health Technologies In Poland
Value in Health, 2016, 19, A447-A448
1.90Citations (PDF)
353Ten-year kidney transplant survival of cyclosporine- or tacrolimus-treated patients in Brazil2.515Citations (PDF)
354Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis
Diabetes Therapy, 2016, 7, 241-258
2.022Citations (PDF)
355Antibiotic use in acute respiratory infections in under-fives in Uganda: findings and implications3.858Citations (PDF)
356Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future2.58Citations (PDF)
357Switching among Equivalents in Chronic Cardiovascular Therapies: ‘Real World’ Data from Italy2.81Citations (PDF)
358Utilisation of the ESMO-MCBS in practice of HTA
Annals of Oncology, 2016, 27, 2134-2136
9.947Citations (PDF)
359Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia3.8126Citations (PDF)
360Comparative effectiveness of adalimumab and etanercept for rheumatoid arthritis in the Brazilian Public Health System2.314Citations (PDF)
361Comparing twice- versus four-times daily insulin in mothers with gestational diabetes in Pakistan and its implications2.35Citations (PDF)
362Time trends in statin utilisation and coronary mortality in Western European countries
BMJ Open, 2016, 6, e010500
1.973Citations (PDF)
363Do newly marketed generic medicines expand markets using descriptive time series analysis and mixed logit models? Korea as an exemplar and its implications2.513Citations (PDF)
364The prescribing of generic medicines in Nigeria: knowledge, perceptions and attitudes of physicians1.465Citations (PDF)
365Prevalence of Vitamin D deficiency in Pakistan and implications for the future2.564Citations (PDF)
366Quality of life of patients with Diabetes Mellitus Types 1 and 2 from a referal health centre in Minas Gerais, Brazil2.538Citations (PDF)
367A review of trials investigating efavirenz-induced neuropsychiatric side effects and the implications3.851Citations (PDF)
368Budget impact analysis of medicines: updated systematic review and implications1.441Citations (PDF)
369Cost driver analysis of statin expenditure on Australia’s Pharmaceutical Benefits Scheme1.44Citations (PDF)
370Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future1.418Citations (PDF)
371Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications2.549Citations (PDF)
372Personalising medicine: Feasibility and future implications from a payers' perspective0.02Citations (PDF)
373Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan: implications for the future
GaBI Journal, 2016, 5, 156-163
0.124Citations (PDF)
374The establishment and expansion of an innovative centre for rational pharmacotherapy—determinants and challenges1.76Citations (PDF)
375Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future0.538Citations (PDF)
376The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental design2.514Citations (PDF)
377Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review
Pharmacoeconomics, 2015, 33, 905-924
3.683Citations (PDF)
378Initiatives in South Africa to enhance the prescribing of generic proton pump inhibitors: findings and implications2.31Citations (PDF)
379The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications3.871Citations (PDF)
380Key Components of Increased Drug Expenditure in South Korea: Implications for the Future1.38Citations (PDF)
381Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature3.8196Citations (PDF)
382Prescribing efficiency of proton pump inhibitors in China: influence and future directions2.530Citations (PDF)
383Quality Indicators as a Tool in Improving the Introduction of New Medicines2.836Citations (PDF)
384Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Kedah, Malaysia, and the implications3.846Citations (PDF)
385Are new models needed to optimize the utilization of new medicines to sustain healthcare systems?2.5115Citations (PDF)
386Pro-Arrhythmic Potential of Oral Antihistamines (H1): Combining Adverse Event Reports with Drug Utilization Data across Europe
PLoS ONE, 2015, 10, e0119551
2.358Citations (PDF)
387Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance
GaBI Journal, 2015, 4, 79-89
0.17Citations (PDF)
388Generic pregabalin; current situation and implications for health authorities, generics and biosimilars manufacturers in the future
GaBI Journal, 2015, 4, 125-135
0.111Citations (PDF)
389Bioequivalence of narrow therapeutic index drugs and immunosuppressives
GaBI Journal, 2015, 4, 159-160
0.13Citations (PDF)
390Measures to improve angiotensin receptor blocker prescribing efficiency in the UK: findings and implications2.327Citations (PDF)
391Dabigatran - a continuing exemplar case history demonstrating the need for comprehensive models to optimize the utilization of new drugs3.845Citations (PDF)
392Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications3.8111Citations (PDF)
393Different initiatives across Europe to enhance losartan utilization post generics: impact and implications3.850Citations (PDF)
394An Analytical Framework for Assessing Drug and Therapeutics Committee Structure and Work Processes in Tertiary Brazilian Hospitals2.825Citations (PDF)
395Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications
BMC Medicine, 2014, 12,
7.138Citations (PDF)
396Authors’ Reply to Dr. Malerbi: “Insulin Glargine in a Brazilian State: Should the Government Disinvest?”2.52Citations (PDF)
397Insulin Glargine in a Brazilian State: Should the Government Disinvest? An Assessment Based on a Systematic Review2.549Citations (PDF)
398Diffusion of e-health innovations in ‘post-conflict’ settings: a qualitative study on the personal experiences of health workers3.136Citations (PDF)
399Analysis of the influence of recent reforms in China: cardiovascular and cerebrovascular medicines as a case history to provide future direction2.315Citations (PDF)
400Ongoing initiatives to improve prescribing efficiency in China; statins as a case history
GaBI Journal, 2014, 3, 122-132
0.16Citations (PDF)
401Availability and procurement of generics in hospitals among medium-sized European countries
GaBI Journal, 2014, 3, 162-163
0.11Citations (PDF)
402Influence of multiple initiatives in Sweden to enhance ARB prescribing efficiency following generic losartan; findings and implications for other countries3.025Citations (PDF)
403Changes in the Utilization of Venlafaxine after the Introduction of Generics in Sweden2.527Citations (PDF)
404Impact of Delisting ARBs, Apart from Losartan, on ARB Utilisation Patterns in Denmark: Implications for Other Countries2.516Citations (PDF)
405A New Reimbursement System for Innovative Pharmaceuticals Combining Value-Based and Free Market Pricing2.517Citations (PDF)
406Price cuts and drug spending in South Korea: The case of antihyperlipidemic agents
Health Policy, 2013, 112, 217-226
2.733Citations (PDF)
407Are specific initiatives required to enhance prescribing of generic atypical antipsychotics in Scotland?: International implications3.012Citations (PDF)
408Personalizing health care: feasibility and future implications
BMC Medicine, 2013, 11,
7.186Citations (PDF)
409Multilevel Analysis of the Influence of Patients’ and General Practitioners’ Characteristics on Patented Versus Multiple-Sourced Statin Prescribing in France2.511Citations (PDF)
410Generic atypical antipsychotic drugs in Belgium: their influence and implications2.315Citations (PDF)
411Measures to enhance angiotensin-receptor blocker prescribing efficiency in Belgium following generic losartan: impact and implications for the future0.58Citations (PDF)
412Can authorities take advantage of the availability of generic atypical antipsychotic drugs? Findings from Sweden and potential implications0.59Citations (PDF)
413Reforms and initiatives in Scotland in recent years to encourage the prescribing of generic drugs, their influence and implications for other countries1.477Citations (PDF)
414Potential to Enhance the Prescribing of Generic Drugs in Patients with Mental Health Problems in Austria; Implications for the Future3.813Citations (PDF)
415Dabigatran – a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs3.879Citations (PDF)
416Torsadogenic Risk of Antipsychotics: Combining Adverse Event Reports with Drug Utilization Data across Europe
PLoS ONE, 2013, 8, e81208
2.355Citations (PDF)
417Health authority perspective on biosimilars
GaBI Journal, 2013, 2, 10-11
0.18Citations (PDF)
418National and regional activities by sickness funds in Austria to encourage the rational use of medicines
GaBI Journal, 2013, 2, 58-59
0.10Citations (PDF)
419Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency; influence and future directions
GaBI Journal, 2013, 2, 112-113
0.11Citations (PDF)
420Update of Recent Reforms in Germany to Enhance the Quality and Efficiency of Prescribing of Proton Pump Inhibitors and Lipid-Lowering Drugs
Pharmacoeconomics, 2012, 27, 435-438
3.634Citations (PDF)
421Influence of Patient Co-Payments on Atypical Antipsychotic Choice in Poland2.524Citations (PDF)
422Multiple initiatives continue to enhance the prescribing efficiency for the proton pump inhibitors and statins in Scotland1.472Citations (PDF)
423International Variability in the Reimbursement of Cancer Drugs by Publically Funded Drug Programs
Current Oncology, 2012, 19, 165-176
3.077Citations (PDF)
424Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications2.388Citations (PDF)
425Possible ways to enhance renin–angiotensin prescribing efficiency: Republic of Serbia as a case history?2.311Citations (PDF)
426Ongoing initiatives in the Republic of Srpska to enhance prescribing efficiency: influence and future directions1.431Citations (PDF)
427Influence of lifting prescribing restrictions for losartan on subsequent sartan utilization patterns in Austria: implications for other countries1.416Citations (PDF)
428European payer initiatives to reduce prescribing costs through use of generics
GaBI Journal, 2012, 1, 22-27
0.134Citations (PDF)
429Payers endorse generics to enhance prescribing efficiency: impact and future implications, a case history approach
GaBI Journal, 2012, 1, 69-83
0.143Citations (PDF)
430PHP49 Developing Risk Sharing Arrangements – Potential for Brazil and Implications
Value in Health, 2011, 14, A557
1.91Citations (PDF)
431Policies to Enhance Prescribing Efficiency in Europe: Findings and Future Implications3.892Citations (PDF)
432The ‘Wise List’– A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm2.8195Citations (PDF)
433Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?
Pharmaceuticals, 2010, 3, 2470-2494
4.281Citations (PDF)
434Forecasting drug utilization and expenditure in a metropolitan health region2.563Citations (PDF)
435Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers2.5218Citations (PDF)
436Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implications1.464Citations (PDF)
437Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment
Health Policy, 2010, 94, 221-229
2.765Citations (PDF)
438Getting better value from the NHS drug budget
BMJ: British Medical Journal, 2010, 341, c6449-c6449
0.125Citations (PDF)
439Policies to enhance the efficiency of prescribing in the Spanish Catalan region: impact and future direction1.440Citations (PDF)
440Potential savings without compromising the quality of care3.049Citations (PDF)
441Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance1.4128Citations (PDF)
442Impact of recent reforms in Austria on utilization and expenditure of PPIs and lipid-lowering drugs: implications for the future1.449Citations (PDF)
443Insight into recent reforms and initiatives in Austria: implications for key stakeholders1.459Citations (PDF)
444Generic olanzapine: health authority opportunity or nightmare?1.424Citations (PDF)
445Current National Initiatives and Policies to Control Drug Costs in Europe0.811Citations (PDF)
446Economics of Myocardial Perfusion Imaging in Europe—the EMPIRE study
European Heart Journal, 1999, 20, 157-166
2.2149Citations (PDF)
447General practitioners’ knowledge, attitude and prescribing of antibiotics for upper respiratory tract infections in Selangor, Malaysia: findings and implications3.839Citations (PDF)
448Evaluation of Namibia’s antiretroviral therapy guidelines’ recommendations for switching from first-line to second-line, using predictors of first-line treatment failure: an exploratory study3.80Citations (PDF)
449Adoption of new therapies in the treatment of Hepatitis: a verification of the accuracy of budget impact analysis to guide investment decisions1.44Citations (PDF)
450Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh0.51Citations (PDF)
451Assessing the management of patients with type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: A pilot study0.51Citations (PDF)
452Current access, availability and use of antibiotics in primary care among key low- and middle-income countries and the policy implications3.834Citations (PDF)
453Patient knowledge, attitudes and behaviors related to antimicrobial use in South African primary healthcare settings: development and testing of the CAMUS and its implications1.86Citations (PDF)
454Public health financing in Brazil (2019–2022): an analysis of the national health fund and implications for health management2.79Citations (PDF)
455Global variation in antibiotic prescribing guidelines and the implications for decreasing AMR in the future3.818Citations (PDF)
456Oral cholera vaccine uptake, acceptance and confidence among residents of a high-risk township in Zambia: key insights for future vaccination programs
International Health, 0, 18, 254-263
2.31Citations (PDF)
457Potential activities to improve primary care prescribing of antibiotics across Africa1.82Citations (PDF)
458Estimated extent of purchasing of antibiotics without a prescription from community pharmacies in a rural province in South Africa and the implications1.86Citations (PDF)
459Users’ Perspectives on Primary Care and Public Health Services in the State of Rio de Janeiro, Brazil: A Cross-Sectional Study with Implications for Healthcare Quality Assessment2.90Citations (PDF)
460Potential activities to reduce the extent of substandard and falsified antibiotics across Africa and associated antimicrobial resistance1.83Citations (PDF)
461Quality of Care for Hypertension in Primary Health Care in South Africa: Cross-Sectional Feasibility Study2.11Citations (PDF)
462Assessment of Medical Students’ Knowledge, Attitude, and Practice Regarding Antibiotics and Antimicrobial Resistance: Insights from a Cross-Sectional Study
0, 2, 16-23
11Citations (PDF)
463Current knowledge and attitudes toward antibiotic use among community pharmacy personnel in a rural province in South Africa and the implications1.84Citations (PDF)
464Antimicrobial Stewardship Program Implementation, Perceptions, and Barriers in Zambia: A Cross-Sectional Study Among Healthcare Professionals
Antibiotics, 0, 14, 1094
4.10Citations (PDF)
465Quantitative Polymerase Chain Reaction Identified a Multitude of mcr-1 to mcr-5 Genes in Fresh Cow Dung in Bangladesh: An Urgent Public Health Concern0.30Citations (PDF)
466Antibiotic Shortages among Public Sector Hospitals Across Sub-Saharan Africa: A Protocol for an Electronic Survey to Gain Understanding0.31Citations (PDF)
467Quality of different brands of clarithromycin tablets marketed in Ethiopia; implications for the future1.80Citations (PDF)
468Prevalence and Associated Factors for Purchasing Antibiotics Without a Prescription Among Patients in Rural South Africa: Implications for Addressing Antimicrobial Resistance
Antibiotics, 0, 14, 1273
4.14Citations (PDF)
469A qualitative exploration of stakeholders' views on vaccines for the elderly in South Africa
Vaccine: X, 0, 29, 100779
1.70Citations (PDF)
470Psychometric Validation of the Community Antimicrobial Use Scale (CAMUS) in Primary Healthcare and the Implications for Future Use
Antibiotics, 0, 15, 107
4.10Citations (PDF)
471Challenges regarding the provision of antibiotics via the informal sector across low- and middle-income countries and potential ways forward
0, 22, 14-30
3Citations (PDF)
472Development of AWaRe-Based Quality Indicators to Assess the Appropriateness of Antibiotic Prescribing in Primary Healthcare in South Africa
Antibiotics, 0, 15, 196
4.11Citations (PDF)
473Trends in Antimicrobial Consumption in Pakistan (2016‐2028): Retrospective Observational Study With Forecasting3.80Citations (PDF)
474Balancing public health needs and economic sustainability: A dual-matrix model for community pharmacy inventory management0.70Citations (PDF)
475Factors associated with inappropriate antibiotic use in South African communities: findings from the CAMUS survey3.80Citations (PDF)
476Alignment of national standard treatment guidelines with WHO AWaRe recommendations for adult primary care infectious diseases: implications for antimicrobial stewardship3.11Citations (PDF)
477Exploring the drivers of low DPT3 vaccination coverage and the implications in rural, urban and peri-urban Uganda: a cross-sectional study of Hoima and Wakiso districts of Uganda3.10Citations (PDF)
478Non-prescription antibiotic dispensing and counseling practices in Iraqi community pharmacies: implications for antimicrobial stewardship and resistance containment3.80Citations (PDF)
479Cost and clinical analysis of community-acquired pneumonia within an antimicrobial stewardship-governed academic hospital in South Africa, and its implications1.40Citations (PDF)
480Antibiotic utilization in outpatient and inpatient hospitals in Zambia: a systematic review, key findings and public health implications1.20Citations (PDF)
481Barriers to physical activity among pharmacy undergraduates at Universiti Malaya, Malaysia: profiles and associated factors from a cross-sectional study3.10Citations (PDF)
482The Applicability of AWaRe-Based Antibiotic Quality Indicators to Assess the Appropriateness of Antibiotic Prescribing in Primary Healthcare in South Africa: A Multicentre Point Prevalence Study and Implications for the Future
Antibiotics, 0, 15, 562
4.10Citations (PDF)
483Acceptability of Hypertension Quality Indicators in Primary Care in South Africa: Exploratory Implementation Research2.10Citations (PDF)